Methods of treating retinal disorders with anti-apelin antibodies
US9493554B2 · kind B2 · utility
0Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2015 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Aug 28, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7014
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to apelin antigen-binding proteins and methods of using the apelin antigen-binding proteins. The antigen-binding protein may comprise an antibody to apelin and can be used to treat pathological conditions involving angiogenesis. The pathological conditions can comprise cancer or retinopathy and/or retinopathy-related complications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.